Comparison of Non-Invasive Blood Pressure (NIBP) Using the Biobeat Device with an Invasive Arterial Line Catheter
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBiobeat Technologies Ltd.
About this trial
In this clinical study the investigators will compare blood pressure measurements obtained using the non-invasive, wireless Biobeat monitoring device (both a wrist watch and a patch configuration) to an invasive arterial line catheter (radial or femoral) and a Swan Ganz Catheter in 20 patients immediately after cardiac surgery, at the cardiac intensive care unit.
Eligibility criteria
Qualifiers
18 years old and above patients of both sexes arriving immediately after cardiac surgery to the intensive care unit with a radial/femoral arterial line and or a Swan Ganz catheter and in need for blood pressure monitoring.
Disqualifiers
Refusal to participate
Patients with no need or no technical capability to have an arterial line
Pregnant women
Individuals under the age of 18 years
Trial design
Treatments tested in this trial
- Non-invasive monitoring
Treatment groups
No treatment groups listed
Sponsors and collaborators
Biobeat Technologies Ltd.
Lead sponsor
The Chaim Sheba Medical Center
Collaborator
Source ClinicalTrials.gov